Loading company…
Terray Therapeutics is a Monrovia biotech using advanced platforms for drug discovery in oncology and autoimmune disorders.
Founded in 2018 and based in Monrovia, California, US, Terray Therapeutics offers computational tools and high-throughput screening to help pharmaceutical and biotech companies identify drug candidates for oncology and autoimmune disorders. Eli Berlin is the founder and Jacob Berlin is CEO. The company raised USD 120.00 mn in a Series B round on October 17, 2024, at a current valuation of USD 344.63 mn, after six deals to date.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in